rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2010-9-23
|
pubmed:abstractText |
Several markers have been proposed to predict the outcome of chronic lymphocytic leukemia (CLL) patients. However, discordances exist between the current prognostic factors, indicating that none of these factors are totally perfect.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:meshHeading |
pubmed-meshheading:20862275-Adult,
pubmed-meshheading:20862275-Aged,
pubmed-meshheading:20862275-Aged, 80 and over,
pubmed-meshheading:20862275-Female,
pubmed-meshheading:20862275-Follow-Up Studies,
pubmed-meshheading:20862275-Humans,
pubmed-meshheading:20862275-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:20862275-Male,
pubmed-meshheading:20862275-Middle Aged,
pubmed-meshheading:20862275-Polymerase Chain Reaction,
pubmed-meshheading:20862275-Prognosis,
pubmed-meshheading:20862275-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients.
|
pubmed:affiliation |
Laboratory of Experimental Hematology, Faculty of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. bstamato@ulb.ac.be
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|